These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. In-vitro activity of imipenem/relebactam and key β-lactam agents against Gram-negative bacilli isolated from lower respiratory tract infection samples of intensive care unit patients - SMART Surveillance United States 2015-2017. Karlowsky JA; Lob SH; Kazmierczak KM; Young K; Motyl MR; Sahm DF Int J Antimicrob Agents; 2020 Jan; 55(1):105841. PubMed ID: 31704217 [TBL] [Abstract][Full Text] [Related]
5. Activity of imipenem-relebactam against multidrug-resistant Pseudomonas aeruginosa from the United States - SMART 2015-2017. Karlowsky JA; Lob SH; Young K; Motyl MR; Sahm DF Diagn Microbiol Infect Dis; 2019 Oct; 95(2):212-215. PubMed ID: 31174995 [TBL] [Abstract][Full Text] [Related]
6. Imipenem-Relebactam and Meropenem-Vaborbactam: Two Novel Carbapenem-β-Lactamase Inhibitor Combinations. Zhanel GG; Lawrence CK; Adam H; Schweizer F; Zelenitsky S; Zhanel M; Lagacé-Wiens PRS; Walkty A; Denisuik A; Golden A; Gin AS; Hoban DJ; Lynch JP; Karlowsky JA Drugs; 2018 Jan; 78(1):65-98. PubMed ID: 29230684 [TBL] [Abstract][Full Text] [Related]
7. In vitro activity of imipenem/relebactam against Gram-negative ESKAPE pathogens isolated in 17 European countries: 2015 SMART surveillance programme. Karlowsky JA; Lob SH; Kazmierczak KM; Hawser SP; Magnet S; Young K; Motyl MR; Sahm DF J Antimicrob Chemother; 2018 Jul; 73(7):1872-1879. PubMed ID: 29659861 [TBL] [Abstract][Full Text] [Related]
8. Activity of Imipenem with Relebactam against Gram-Negative Pathogens from New York City. Lapuebla A; Abdallah M; Olafisoye O; Cortes C; Urban C; Landman D; Quale J Antimicrob Agents Chemother; 2015 Aug; 59(8):5029-31. PubMed ID: 26014931 [TBL] [Abstract][Full Text] [Related]
9. Invitro activity of imipenem-relebactam against gram-negative bacilli isolated from patients with lower respiratory tract infections in the United States in 2015 - Results from the SMART global surveillance program. Lob SH; Hackel MA; Kazmierczak KM; Hoban DJ; Young K; Motyl MR; Karlowsky JA; Sahm DF Diagn Microbiol Infect Dis; 2017 Jun; 88(2):171-176. PubMed ID: 28291628 [TBL] [Abstract][Full Text] [Related]
10. Relebactam Is a Potent Inhibitor of the KPC-2 β-Lactamase and Restores Imipenem Susceptibility in KPC-Producing Enterobacteriaceae. Papp-Wallace KM; Barnes MD; Alsop J; Taracila MA; Bethel CR; Becka SA; van Duin D; Kreiswirth BN; Kaye KS; Bonomo RA Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29610205 [TBL] [Abstract][Full Text] [Related]
11. Simultaneous and divergent evolution of resistance to cephalosporin/β-lactamase inhibitor combinations and imipenem/relebactam following ceftazidime/avibactam treatment of MDR Pseudomonas aeruginosa infections. Alonso-García I; Vázquez-Ucha JC; Lasarte-Monterrubio C; González-Mayo E; Lada-Salvador P; Vela-Fernández R; Aja-Macaya P; Guijarro-Sánchez P; Rumbo-Feal S; Muíño-Andrade M; Fernández-González A; Martínez-Guitián M; Beceiro A; Rodríguez-Iglesias M; Oliver A; Arca-Suárez J; Galán-Sánchez F; Bou G J Antimicrob Chemother; 2023 May; 78(5):1195-1200. PubMed ID: 36918743 [TBL] [Abstract][Full Text] [Related]
12. In vitro studies evaluating the activity of imipenem in combination with relebactam against Pseudomonas aeruginosa. Young K; Painter RE; Raghoobar SL; Hairston NN; Racine F; Wisniewski D; Balibar CJ; Villafania A; Zhang R; Sahm DF; Blizzard T; Murgolo N; Hammond ML; Motyl MR BMC Microbiol; 2019 Jul; 19(1):150. PubMed ID: 31272373 [TBL] [Abstract][Full Text] [Related]
13. In vitro activity of imipenem-relebactam against various resistance phenotypes/genotypes of Enterobacterales and Pseudomonas aeruginosa isolated from patients across Canada as part of the CANWARD study, 2016-2019. Walkty A; Karlowsky JA; Baxter MR; Adam HJ; Golden A; Lagace-Wiens P; Zhanel GG; Diagn Microbiol Infect Dis; 2021 Sep; 101(1):115418. PubMed ID: 34102373 [TBL] [Abstract][Full Text] [Related]
14. Activity of imipenem/relebactam against Pseudomonas aeruginosa with antimicrobial-resistant phenotypes from seven global regions: SMART 2015-2016. Karlowsky JA; Lob SH; Young K; Motyl MR; Sahm DF J Glob Antimicrob Resist; 2018 Dec; 15():140-147. PubMed ID: 30071354 [TBL] [Abstract][Full Text] [Related]